Lipocalin-2-mediated astrocyte pyroptosis promotes neuroinflammatory injury via NLRP3 inflammasome activation in cerebral ischemia/reperfusion injury

被引：0
|
作者：
Juanji Li
Pengfei Xu
Ye Hong
Yi Xie
Mengna Peng
Rui Sun
Hongquan Guo
Xiaohao Zhang
Wusheng Zhu
Junjun Wang
Xinfeng Liu
机构：
[1] Nanjing University,Department of Neurology, Nanjing Jinling Hospital, Affiliated Hospital of Medical School
[2] University of Science and Technology of China,Division of Life Sciences and Medicine, Department of Neurology, The First Affiliated Hospital of USTC
[3] Nanjing Medical University,Department of Neurology, Nanjing First Hospital
[4] Second Military Medical University/Naval Medical University,Department of Neurology, Shanghai Changhai Hospital
[5] Medical School of Nanjing University,Department of Clinical Laboratory, Affiliated Jinling Hospital
来源：
Journal of Neuroinflammation | / 20卷
关键词：
Cerebral ischemia/reperfusion injury; Astrocyte; Pyroptosis; LCN2; NLRP3 inflammasome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Lipocalin-2-mediated astrocyte pyroptosis promotes neuroinflammatory injury via NLRP3 inflammasome activation in cerebral ischemia/reperfusion injury
    Li, Juanji
    Xu, Pengfei
    Hong, Ye
    Xie, Yi
    Peng, Mengna
    Sun, Rui
    Guo, Hongquan
    Zhang, Xiaohao
    Zhu, Wusheng
    Wang, Junjun
    Liu, Xinfeng
    JOURNAL OF NEUROINFLAMMATION, 2023, 20 (01)
  • [2] NLRP3 Inflammasome Activation: A Therapeutic Target for Cerebral Ischemia-Reperfusion Injury
    Wang, Lixia
    Ren, Wei
    Wu, Qingjuan
    Liu, Tianzhu
    Wei, Ying
    Ding, Jiru
    Zhou, Chen
    Xu, Houping
    Yang, Sijin
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2022, 15
  • [3] Periostin aggravates NLRP3 inflammasome-mediated pyroptosis in myocardial ischemia-reperfusion injury
    Yao, Lei
    Song, Jie
    Meng, Xiao Wen
    Ge, Jian Yun
    Du, Bo Xiang
    Yu, Jun
    Ji, Fu Hai
    MOLECULAR AND CELLULAR PROBES, 2020, 53
  • [4] Cardioprotective effect of cinnamaldehyde pretreatment on ischemia/reperfusion injury via inhibiting NLRP3 inflammasome activation and gasdermin D mediated cardiomyocyte pyroptosis
    Luan, Fei
    Lei, Ziqin
    Peng, Xi
    Chen, Li
    Peng, Lixia
    Liu, Yao
    Rao, Zhili
    Yang, Ruocong
    Zeng, Nan
    CHEMICO-BIOLOGICAL INTERACTIONS, 2022, 368
  • [5] Piperazine ferulate protects against cardiac ischemia/reperfusion injury in rat via the suppression of NLRP3 inflammasome activation and pyroptosis
    Lei, Ziqin
    Luan, Fei
    Zhang, Xia
    Peng, Lixia
    Li, Bo
    Peng, Xi
    Liu, Yao
    Liu, Rong
    Zeng, Nan
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 920
  • [6] Protective effects of oridonin against cerebral ischemia/reperfusion injury by inhibiting the NLRP3 inflammasome activation
    Jia, Yujie
    Tong, Yu
    Min, Lianqiu
    Li, Yanrong
    Cheng, Yan
    TISSUE & CELL, 2021, 71
  • [7] Daucosterol pretreatment ameliorates myocardial ischemia reperfusion injury via ROS-mediated NLRP3 inflammasome activation
    Zhao, Guixiang
    Ma, Xiaoyun
    Juledezi-Hailati
    Bao, Zhen
    Maerjiaen-Bakeyi
    Liu, Zhiqiang
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2020, 19 (05) : 1031 - 1036
  • [8] Geniposide suppresses NLRP3 inflammasome-mediated pyroptosis via the AMPK signaling pathway to mitigate myocardial ischemia/reperfusion injury
    Haiyan Li
    Dong-Hua Yang
    Yanmei Zhang
    Fuchun Zheng
    Fenfei Gao
    Jiajia Sun
    Ganggang Shi
    Chinese Medicine, 17
  • [9] Protective Effects of Remimazolam on Cerebral Ischemia/Reperfusion Injury in Rats by Inhibiting of NLRP3 Inflammasome-Dependent Pyroptosis
    Shi, Min
    Chen, Jing
    Liu, Tianxiao
    Dai, Weixin
    Zhou, Zhan
    Chen, Lifei
    Xie, Yubo
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 413 - 423
  • [10] Geniposide suppresses NLRP3 inflammasome-mediated pyroptosis via the AMPK signaling pathway to mitigate myocardial ischemia/reperfusion injury
    Li, Haiyan
    Yang, Dong-Hua
    Zhang, Yanmei
    Zheng, Fuchun
    Gao, Fenfei
    Sun, Jiajia
    Shi, Ganggang
    CHINESE MEDICINE, 2022, 17 (01)
12345